​

Regeneron Pharmaceuticals (REGN) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Regeneron Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$14.34B

Latest Revenue (Q)

$3.75B

Main Segment (Y)

Collaboration Revenue

Main Geography (Y)

UNITED STATES

Regeneron Pharmaceuticals Revenue by Period

Regeneron Pharmaceuticals Revenue by Year

DateRevenueChange
2025-12-31$14.34B0.99%
2024-12-31$14.20B8.27%
2023-12-31$13.12B7.76%
2022-12-31$12.17B-24.26%
2021-12-31$16.07B89.14%
2020-12-31$8.50B29.58%
2019-12-31$6.56B-2.28%
2018-12-31$6.71B14.28%
2017-12-31$5.87B20.82%
2016-12-31$4.86B18.44%
2015-12-31$4.10B45.55%
2014-12-31$2.82B33.96%
2013-12-31$2.10B52.69%
2012-12-31$1.38B209.20%
2011-12-31$445.82M-2.89%
2010-12-31$459.07M21.04%
2009-12-31$379.27M59.05%
2008-12-31$238.46M90.73%
2007-12-31$125.02M97.05%
2006-12-31$63.45M-4.15%
2005-12-31$66.19M-61.96%
2004-12-31$174.02M202.65%
2003-12-31$57.50M161.49%
2002-12-31$21.99M0.07%
2001-12-31$21.97M-62.93%
2000-12-31$59.28M71.81%
1999-12-31$34.50M-9.69%
1998-12-31$38.20M15.41%
1997-12-31$33.10M37.34%
1996-12-31$24.10M-12.04%
1995-12-31$27.40M18.10%
1994-12-31$23.20M118.87%
1993-12-31$10.60M-

Regeneron Pharmaceuticals generated $14.34B in revenue during NA 2025, up 0.99% compared to the previous quarter, and up 168.80% compared to the same period a year ago.

Regeneron Pharmaceuticals Revenue by Quarter

DateRevenueChange
2025-09-30$3.75B2.14%
2025-06-30$3.68B21.36%
2025-03-31$3.03B-20.07%
2024-12-31$3.79B1.84%
2024-09-30$3.72B4.89%
2024-06-30$3.55B12.79%
2024-03-31$3.15B-8.42%
2023-12-31$3.43B2.13%
2023-09-30$3.36B6.48%
2023-06-30$3.16B-0.13%
2023-03-31$3.16B-7.39%
2022-12-31$3.41B16.29%
2022-09-30$2.94B2.76%
2022-06-30$2.86B-3.64%
2022-03-31$2.97B-40.12%
2021-12-31$4.95B43.41%
2021-09-30$3.45B-32.81%
2021-06-30$5.14B103.21%
2021-03-31$2.53B4.37%
2020-12-31$2.42B5.62%
2020-09-30$2.29B17.52%
2020-06-30$1.95B6.77%
2020-03-31$1.83B-1.89%
2019-12-31$1.86B6.87%
2019-09-30$1.74B10.51%
2019-06-30$1.58B14.95%
2019-03-31$1.37B-28.80%
2018-12-31$1.93B15.89%
2018-09-30$1.66B3.45%
2018-06-30$1.61B6.39%
2018-03-31$1.51B-4.48%
2017-12-31$1.58B5.45%
2017-09-30$1.50B2.08%
2017-06-30$1.47B11.46%
2017-03-31$1.32B7.51%
2016-12-31$1.23B0.55%
2016-09-30$1.22B0.62%
2016-06-30$1.21B0.98%
2016-03-31$1.20B9.36%
2015-12-31$1.10B-3.46%
2015-09-30$1.14B13.90%
2015-06-30$998.62M14.83%
2015-03-31$869.61M8.39%
2014-12-31$802.33M10.55%
2014-09-30$725.79M9.03%
2014-06-30$665.70M6.39%
2014-03-31$625.74M2.51%
2013-12-31$610.41M2.24%
2013-09-30$597.03M30.46%
2013-06-30$457.64M4.09%
2013-03-31$439.66M6.04%
2012-12-31$414.60M-3.06%
2012-09-30$427.69M40.50%
2012-06-30$304.40M31.33%
2012-03-31$231.79M88.48%
2011-12-31$122.98M19.59%
2011-09-30$102.83M-4.62%
2011-06-30$107.81M-3.92%
2011-03-31$112.20M-16.06%
2010-12-31$133.68M26.13%
2010-09-30$105.98M-8.55%
2010-06-30$115.89M11.93%
2010-03-31$103.53M6.96%
2009-12-31$96.80M-17.59%
2009-09-30$117.45M30.46%
2009-06-30$90.03M20.07%
2009-03-31$74.98M34.29%
2008-12-31$55.84M-14.86%
2008-09-30$65.58M8.13%
2008-06-30$60.65M7.57%
2008-03-31$56.38M-

Regeneron Pharmaceuticals generated $3.75B in revenue during Q3 2025, up 2.14% compared to the previous quarter, and up 105.84% compared to the same period a year ago.

Regeneron Pharmaceuticals Revenue Breakdown

Regeneron Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24Dec 23Dec 22Dec 21
Product$6.31B$7.63B$7.08B$6.89B$12.12B
Product and Service, Other$702.60M$515.00M$536.10M$365.10M$281.20M
Collaboration Revenue$7.33B$6.06B$5.50B$2.06B-

Regeneron Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 25: Collaboration Revenue (51.11%), Product (43.99%), and Product and Service, Other (4.90%).

Quarterly Revenue by Product

Product/ServiceDec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
Product$1.67B$1.59B$1.63B$1.42B$2.00B$1.95B$1.92B$1.76B$1.85B$1.79B$1.77B$1.67B$1.70B$1.80B$1.75B$1.64B$3.98B$2.28B$4.14B$1.72B
Collaboration Revenue$1.97B$1.97B$1.86B$1.53B$1.61B$1.66B$1.52B$1.27B$1.37B$1.44B$1.32B$1.38B$-1.27B$1.05B$1.04B$1.23B$1.07B$954.70M$754.40M-
Product and Service, Other$238.60M$198.20M$183.90M$81.90M$179.40M$114.20M$104.50M$116.90M$212.50M$138.30M$69.30M$116.00M$127.70M$84.20M$59.20M$94.00M$86.20M$99.00M$46.00M$50.00M

Regeneron Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Collaboration Revenue (50.74%), Product (43.12%), and Product and Service, Other (6.14%).

Regeneron Pharmaceuticals Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 25Dec 24Dec 23Dec 22Dec 21
UNITED STATES$4.38B$5.97B$5.89B$130.00M$5.83B
Rest Of World$507.50M$429.50M$324.30M$73.00M-
Non-US--$324.30M--

Regeneron Pharmaceuticals's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (89.63%), and Rest Of World (10.37%).

Quarterly Revenue by Country

CountryDec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
Rest Of World$361.40M$146.10M$128.70M$92.60M$115.70M$94.10M$115.00M$104.70M$89.00M$88.30M$79.80M$67.20M$42.00M$31.00M------
UNITED STATES$3.27B$1.11B$1.15B$1.04B$1.50B$1.54B$1.53B$1.40B$1.50B$1.45B$40.50M$40.20M$35.50M$29.70M$31.20M$33.60M$2.30B$676.70M$2.59B$262.20M

Regeneron Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Dec 25: UNITED STATES (90.06%), and Rest Of World (9.94%).

Regeneron Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CORCencora$321.33B$85.93B
CICigna$274.95B$69.75B
ELVElevance Health$199.13B$50.71B
GMABGenmab$16.47B$4.14B
REGNRegeneron Pharmaceuticals$14.34B$3.75B
ZTSZoetis$9.47B$2.40B
INCYIncyte$5.14B$1.37B
IDXXIDEXX Laboratories$4.30B$1.11B
ALNYAlnylam Pharmaceuticals$3.71B$1.25B
UTHRUnited Therapeutics$3.18B$799.50M
ARGXargenx SE$1.23B$401.00M

REGN Revenue FAQ

What is Regeneron Pharmaceuticals’s yearly revenue?

Regeneron Pharmaceuticals's yearly revenue for 2025 was $14.34B, representing an increase of 0.99% compared to 2024. The company's yearly revenue for 2024 was $14.2B, representing an increase of 8.27% compared to 2023. REGN's yearly revenue for 2023 was $13.12B, representing an increase of 7.76% compared to 2022.

What is Regeneron Pharmaceuticals’s quarterly revenue?

Regeneron Pharmaceuticals's quarterly revenue for Q3 2025 was $3.75B, a 2.14% increase from the previous quarter (Q2 2025), and a 0.90% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $3.68B, a 21.36% increase from the previous quarter (Q1 2025), and a 3.62% increase year-over-year (Q2 2024). REGN's quarterly revenue for Q1 2025 was $3.03B, a -20.07% decrease from the previous quarter (Q4 2024), and a -3.70% decrease year-over-year (Q1 2024).

What is Regeneron Pharmaceuticals’s revenue growth rate?

Regeneron Pharmaceuticals's revenue growth rate for the last 3 years (2023-2025) was 9.34%, and for the last 5 years (2021-2025) was -10.76%.

What are Regeneron Pharmaceuticals’s revenue streams?

Regeneron Pharmaceuticals's revenue streams in c 25 are Product, Product and Service, Other, and Collaboration Revenue. Product generated $6.31B in revenue, accounting 43.99% of the company's total revenue, down -17.30% year-over-year. Product and Service, Other generated $702.6M in revenue, accounting 4.90% of the company's total revenue, up 36.43% year-over-year. Collaboration Revenue generated $7.33B in revenue, accounting 51.11% of the company's total revenue, up 21.02% year-over-year.

What is Regeneron Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Regeneron Pharmaceuticals was Collaboration Revenue. This segment made a revenue of $7.33B, representing 51.11% of the company's total revenue.